Print Page  |  Close Window

VYGR

Voyager Therapeutics Inc
Common Stock

$19.36

+0.19
0.99%
Data as of: 02/16/18  4:00 p.m. ET

Corporate Profile

Voyager Therapeutics is developing life-changing gene therapies for fatal and debilitating diseases of the central nervous system.

Our management team has deep expertise and a track record of building exceptional life science companies.

Learn More